Comparison of (+)-methamphetamine, ±-Methylenedioxymethamphetamine, (+)-amphetamine and ±-fenfluramine in rats on egocentric learning in the Cincinnati water maze

Synapse

Volumn 65, Issue 5, 2011, Pages 368-378

  Vorhees, Charles V ^a   He, Elizabeth ^a   Skelton, Matthew R ^a   Graham, Devon L ^a   Schaefer, Tori L ^a   Grace, Curtis E ^a   Braun, Amanda A ^a   Amos Kroohs, Robyn ^a   Williams, Michael T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

(+) amphetamine; 3,4 methylenedioxymethamphetamine; Cincinnati water maze; Egocentric learning; Fenfluramine; Hyperthermia; Maze learning; Methamphetamine; Rat; Route based learning; Swimming maze

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; FENFLURAMINE; METHAMPHETAMINE; SEROTONIN; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG EFFECT; HYPERTHERMIA; LATENT PERIOD; LEARNING; MALE; MAZE TEST; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SWIMMING; TASK PERFORMANCE; VELOCITY;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; BODY WEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; COLD TEMPERATURE; FENFLURAMINE; MALE; MAZE LEARNING; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGENTS; SPATIAL BEHAVIOR; SWIMMING; TIME FACTORS;

EID: 79952208984     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20854     Document Type: Article

References (99)

1. Able JA, Gudelsky GA, Vorhees CV, Williams MT. 2006. 3, 4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biol Psychiatry 59: 1219-1226.
2. Anguiano-Rodriguez PB, Gaytan-Tocaven L, Olvera-Cortes ME. 2007. Striatal serotonin depletion facilitates rat egocentric learning via dopamine modulation. Eur J Pharmacol 556: 91-98.
3. Bae DD, Brown PL, Kiyatkin EA. 2007. Procedure of rectal temperature measurement affects brain, muscle, skin, and body temperatures and modulates the effects of intravenous cocaine. Brain Res 1154: 61-70.
4. Baicy K, London ED. 2007. Corticolimbic dysregulation and chronic methamphetamine abuse. Addiction 102(Suppl 1): 5-15.
5. Balcombe JP, Barnard ND, Sandusky C. 2004. Laboratory routines cause animal stress. Contemp Top Lab Anim Sci 43: 42-51.
6. Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T. 2006. The need for speed: An update on methamphetamine addiction. J Psychiatry Neurosci 31: 301-313.
7. Belcher AM, O'Dell SJ, Marshall JF. 2005. Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity. Neuropsychopharmacology 30: 2026-2034.
8. Benhamou S. 1997. Path integration by swimming rats. Anim Behav 54: 321-327.
9. Bisagno V, Ferguson D, Luine VN. 2002. Short toxic methamphetamine schedule impairs object recognition task in male rats. Brain Res 940: 95-101.
10. Bolla KI, McCann UD, Ricaurte GA. 1998. Memory impairment in abstenent MDMA ("Ecstasy") users. Neurology 51: 1532-1537.
11. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker WJr, Holson RR. 1994. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268: 1571-1580.
12. Bowyer JF, Holson RR. 1995. Methamphetamine and amphetamine neurotoxicity. In: Chang LW, Dyer RS, editors. Handbook of neurotoxicology. New York: Marcel Dekker, Inc. pp 845-870.
13. Bowyer JF, Tank AW, Newport GD, Slikker WJr, Ali SF, Holson RR. 1992. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 260: 817-824.
14. 2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. Synapse 56: 84-93.
15. Broening HW, Pu C, Vorhees CV. 1997. Methamphetamine selectively damages dopaminergic innervation to the nucleus accumbens core while sparing the shell. Synapse 27: 153-160.
16. Byrne RW. 1982. Geographical knowledge and orientation. In: Normality and pathology in cognitive functions. London: Academic Press. pp 239-264.
17. Cappon GD, Broening HW, Pu C, Morford LL. 1996. a-Phenyl-N-tert-butyl nitrone attenuates methamphetamine-induced depletion of striatal dopamine without altering hyperthermia. Synapse 24: 173-181.
18. Chang L, Alicata D, Ernst T, Volkow N. 2007. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102(Suppl 1): 16-32.
19. Clark BJ, Bassett JP, Wang SS, Taube JS. 2010. Impaired head direction cell representation in the anterodorsal thalamus after lesions of the retrosplenial cortex. J Neurosci 30: 5289-5302.
20. Colado MI, Murray TK, Green AR. 1993. 5-HT loss in rat brain following 3, 4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Br J Pharmacol 108: 583-589.
21. Cook D, Kesner RP. 1988. Caudate nucleus and memory for egocentric localization. Behav Neural Biol 49: 332-343.
22. D'Hooge R, De Deyn PP. 2001. Applications of the Morris water maze in the study of learning and memory. Brain Res Rev 36: 60-90.
23. Di FA, Suarez SA. 2007. Route-based travel and shared routes in sympatric spider and woolly monkeys: Cognitive and evolutionary implications. Anim Cogn 10: 317-329.
24. Ellison G, Eison MS, Huberman HS, Daniel F. 1978. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 201: 276-278.
25. EMCDDA. 2007. The State of the Drugs Problem in Europe: Annual Report 2007. Luxembourg. pp 1-100
26. Etienne AS, Jeffery KJ. 2004. Path integration in mammals. Hippocampus 14: 180-192.
27. Finnegan KT, Karler R. 1992. Role for protein synthesis in the neurotoxic effects of methamphetamine in mice and rats. Brain Res 591: 160-164.
28. Friedman SD, Castaneda E, Hodge GK. 1998. Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol Biochem Behav 61: 35-44.
29. Fuhs MC, Touretzky DS. 2006. A spin glass model of path integration in rat medial entorhinal cortex. J Neurosci 26: 4266-4276.
30. Gouzoulis-Mayfrank E, Tuchtenhagen F, Pelz S, Becker S, Kunert H-J, Fimm B, Sass H. 2000. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68: 719-725.
31. Green AR, Mechan AO, Elliott JM, O'shea E, Colado MI. 2003. The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). Pharmacol Rev 55: 463-508.
32. Halpern JH, Pope HGJr, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D. 2004. Residual neuropsychological effects of illicit 3, 4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend 75: 135-147.
33. Han DD, Gu HH. 2006. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6: 6.
34. Harvey J, McMaster S. 1975. Fenfluramine: Evidence for a neurotoxic action on midbrain and a long-term depletion of serotonin. Psychopharmacol Commun 1: 217-228.
35. Haughey HM, Fleckenstein AE, Hanson GR. 1999. Differential regional effects of methamphetamine on the activities of tryptophan and tyrosine hydroxylase. J Neurochem 72: 661-668.
36. Haughey HM, Fleckenstein AE, Metzger RR, Hanson GR. 2000. The effects of methamphetamine on serotonin transporter activity: Role of dopamine and hyperthermia. J Neurochem 75: 1608-1617.
37. He J, Yang Y, Yu Y, Li X, Li XM. 2006. The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats. Behav Brain Res 172: 39-45.
38. Herring NR, Gudelsky GA, Vorhees CV, Williams MT. 2010. (+)-Methamphetamine-induced monoamine reductions and impaired egocentric learning in adrenalectomized rats is independent of hyperthermia. 64: 773-785.
39. Herring NR, Schaefer TL, Gudelsky GA, Vorhees CV, Williams MT. 2008. Effect of (+)-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats. Psychopharmacology (Berl) 199: 637-650.
40. Hotchkiss AJ, Gibb JW. 1980. The long term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214: 257-262.
41. Jacobsen LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH. 2004. Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: Possible relationship to neurotoxic effects. Psychopharmacology (Berl) 173: 383-390.
42. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. 2008. Monitoring the future national survey results on drug use, 1975-2007. Volume II: College students and adults ages 19-45. Bethesda, MD: National Institute on Drug Abuse, NIH Publication Number 08-6418B.
43. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. 2009. Monitoring the future national survey results on drug use, 1975-2008. Volume I: Secondary school students. Bethesda, MD: National Institute on Drug Abuse, NIH Publication Number 09-7402.
44. Kalechstein AD, De La GR, Mahoney JJIII, Fantegrossi WE, Newton TF. 2007. MDMA use and neurocognition: A meta-analytic review. Psychopharmacology (Berl) 189: 531-537.
45. Kenward MG, Roger JH. 1997. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53: 983-997.
46. Kleven MS, Schuster C, Seiden LS. 1988. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. J Pharmacol Exp Ther 246: 822-828.
47. Kokoshka JM, Fleckenstein AE, Wilkins DG, Hanson GR. 2000. Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine. J Neurochem 75: 2095-2102.
48. Kokoshka JM, Metzger RR, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE. 1998. Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain. Brain Res 799: 78-83.
49. Krasnova IN, Ladenheim B, Jayanthi S, Oyler J, Moran TH, Huestis MA, Cadet JL. 2001. Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice: Complex roles for oxygen-based species and temperature regulation. Neuroscience 107: 265-274.
50. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Braman J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W. 2004. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine users. Archiv Gen Psychiatry 61: 73-84.
51. Malberg JE, Seiden LS. 1997. Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles. Brain Res 765: 101-107.
52. McCann UD, Mertl M, Eligulashvili V, Ricaurte GA. 1999. Cognitive performance in (±) 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: A controlled study. Psychopharmacology 143: 417-425.
53. McCann UD, Ridenour A, Shaham Y, Ricaurte GA. 1994. Serotonin neurotoxicity after (+/-)-3, 4-methylenedoxymethamphetamine (MDMA); "Ecstasy"): A controlled study in humans. Neuropsychopharmacology 10: 129-138.
54. McNaughton BL, Battaglia FP, Jensen O, Moser EI, Moser MB. 2006. Path integration and the neural basis of the 'cognitive map'. Nat Rev Neurosci 7: 663-678.
55. Meredith CW, Jaffe C, ng-Lee K, Saxon AJ. 2005. Implications of chronic methamphetamine use: A literature review. Harv Rev Psychiatry 13: 141-154.
56. Metzger RR, Haughey HM, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE. 2000. Methamphetamine-induced rapid decrease in dopamine transporter function: Role of dopamine and hyperthermia. J Pharmacol Exp Ther 295: 1077-1085.
57. Monterosso JR, Aron AR, Cordova X, Xu J, London ED. 2005. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 79: 273-277.
58. Nordahl TE, Salo R, Leamon M. 2003. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. J Neuropsychiatry Clin Neurosci 15: 317-325.
59. O'Callaghan JP, Miller DB. 2002. Neurotoxic effects of substituted amphetamines in rats and mice: Challenges to the current dogma. In: Massaro EJ, editor. Handbook of neurotoxicity. Totowa, NJ: Humana Press. pp 269-301.
60. Peat MA, Warren PF, Bakhit C, Gibb JW. 1985. The acute effects of methamphetamine, amphetamine and p-chloroamphetamine on the cortical serotonergic system of the rat brain: Evidence for differences in the effects of methamphetamine and amphetamine. Eur J Pharmacol 116: 11-16.
61. Potegal M. 1972. The caudate nucleus egocentric localization system. Acta Neurobiol Exp (Wars) 32: 479-494.
62. Pu C, Broening HW, Vorhees CV. 1996. Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex. Synapse 23: 328-334.
63. Pu C, Fisher JE, Cappon GD, Vorhees CV. 1994. The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum. Brain Res 649: 217-224.
64. Pu C, Vorhees CV. 1994. Methamphetamine-induced depletion of glutamate-positive neurons in the somatosensory cortex of the rat. p 1044.
65. Pu C, Vorhees CV. 1995. Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: An immunohistochemical study. Synapse 19: 97-104.
66. Ricaurte GA, Schuster CR, Seiden LS. 1980. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Res 193: 153-163.
67. Riddle EL, Topham MK, Haycock JW, Hanson GR, Fleckenstein AE. 2002. Differential trafficking of vesicular monoamine transporter-2 by methamphetamine and cocaine. Eur J Pharmacol 449: 71-74.
68. Rondi-Reig L, Petit GH, Tobin C, Tonegawa S, Mariani J, Berthoz A. 2006. Impaired sequential egocentric and allocentric memories in forebrain-specific-NMDA receptor knock-out mice during a new task dissociating strategies of navigation. J Neurosci 26: 4071-4081.
69. Rothman RB, Ayestas MA, Dersch CM, Baumann MH. 1999. Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates: Implications for primary pulmonary hypertension. Circulation 100: 869-875.
70. Salo R, Nordahl TE, Moore C, Waters C, Natsuaki Y, Galloway GP, Kile S, Sullivan EV. 2005. A dissociation in attentional control: Evidence from methamphetamine dependence. Biol Psychiatry 57: 310-313.
71. Salo R, Nordahl TE, Natsuaki Y, Leamon MH, Galloway GP, Waters C, Moore CD, Buonocore MH. 2007. Attentional control and brain metabolite levels in methamphetamine abusers. Biol Psychiatry 61: 1272-1280.
72. Salo R, Nordahl TE, Possin K, Leamon M, Gibson DR, Galloway GP, Flynn NM, Henik A, Pfefferbaum A, Sullivan EV. 2002. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res 111: 65-74.
73. Sargolini F, Fyhn M, Hafting T, McNaughton BL, Witter MP, Moser MB, Moser EI. 2006. Conjunctive representation of position, direction, and velocity in entorhinal cortex. Science 312: 758-762.
74. Scheffel U, Steinert C, Kim SE, Ehlers MD, Boja JW, Kuhar MJ. 1996. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35, 428 to central dopamine transporters. Synapse 23: 61-69.
75. Schmitz Y, Lee CJ, Schmauss C, Gonon F, Sulzer D. 2001. Amphetamine distorts stimulation-dependent dopamine overflow: Effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J Neurosci 21: 5916-5924.
76. Schroder N, O'Dell SJ, Marshall JF. 2003. Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse 49: 89-96.
77. Shoblock JR, Maisonneuve IM, Glick SD. 2003a. Differences between d-methamphetamine and d-amphetamine in rats: Working memory, tolerance, and extinction. Psychopharmacology (Berl) 170: 150-156.
78. Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD. 2003b. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology (Berl) 165: 359-369.
79. Shrager Y, Kirwan CB, Squire LR. 2008. Neural basis of the cognitive map: Path integration does not require hippocampus or entorhinal cortex. Proc Natl Acad Sci USA 105: 12034-12038.
80. Skelton MR, Able JA, Grace CE, Herring NR, Schaefer TL, Gudelsky GA, Vorhees CV, Williams MT. 2008. (+/-)-3, 4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: A comparison of single vs once per week treatment for 5 weeks. Neuropharmacology 55: 1121-1130.
81. Skelton MR, Blankenmeyer TL, Gudelsky GA, Brown-Stritthold CA, Vorhees CV, Williams MT. 2004. Metyrapone attenuates the sequential learning deficits but not monoamine depletions following d, l-fenfluramine administration to adult rats. Synapse 54: 214-222.
82. Solstad T, Boccara CN, Kropff E, Moser MB, Moser EI. 2008. Representation of geometric borders in the entorhinal cortex. Science 322: 1865-1868.
83. Sprague JE, Preston AS, Leifheit M, Woodside B. 2003. Hippocampal serotonergic damage induced by MDMA (ecstasy): Effects on spatial learning. Physiol Behav 79: 281-287.
84. Sulzer D, Maidment NT, Rayport S. 1993. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 60: 527-535.
85. Sulzer D, Sonders MS, Poulsen NW, Galli A. 2005. Mechanisms of neurotransmitter release by amphetamines: A review. Prog Neurobiol 75: 406-433.
86. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED. 2004. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24: 6028-6036.
87. Ugarte YV, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE. 2003. Methamphetamine rapidly decreases mouse vesicular dopamine uptake: Role of hyperthermia and dopamine D2 receptors. Eur J Pharmacol 472: 165-171.
88. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J. 2001a. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21: 9414-9418.
89. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN. 2001b. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158: 377-382.
90. Vorhees CV, Herring NR, Schaefer TL, Grace CE, Skelton MR, Johnson HL, Williams MT. 2008. Effects of neonatal (+)-methamphetamine on path integration and spatial learning in rats: Effects of dose and rearing conditions. Int J Dev Neurosci 26: 599-610.
91. Wagner GC, Ricaurte GA, Johanson CE, Schuster CR, Seiden LS. 1980. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 30: 547-550.
92. Wallace TL, Gudelsky GA, Vorhees CV. 2001. Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3, 4-methylenedioxymethamphetamine. Psychopharmacology 153: 321-326.
93. Whishaw IQ. 1998. Place learning in hippocampal rats and the path integration hypothesis. Neurosci Biobehav Res 22: 209-220.
94. Whishaw IQ, McKenna JE, Maaswinkel H. 1997. Hippocampal lesions and path integration. Curr Opin Neurobiol 7: 228-234.
95. Williams MT, Morford LL, McCrea AE, Wood SL, Vorhees CV. 2002. Administration of d, l-fenfluramine produces learning deficits in the Cincinnati water maze but not the Morris water maze: Relationship to adrenal cortical output. Neurotoxicol Teratol 24: 1-14.
96. Witter MP, Moser EI. 2006. Spatial representation and the architecture of the entorhinal cortex. Trends Neurosci 29: 671-678.
97. Wolbers T, Wiener JM, Mallot HA, Buchel C. 2007. Differential recruitment of the hippocampus, medial prefrontal cortex, and the human motion complex during path integration in humans. J Neurosci 27: 9408-9416.
98. Yoshida T. 1997. Use and misuse of amphetamines: An international overview. In: Klee H, editor. Amphetamine misuse: International perspectives on current trends. The Netherlands: Harwood Academic Publishers. pp 1-16.
99. Zaczek R, Battaglia G, Culp S, Appel N, Contrera J, De Souza E. 1990. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: Pharmacokinetic, dose response, regional specificity and time course data. J Pharmacol Exp Ther 253: 104-112.